Phibro Animal Health Corporation (PAHC)
Return on total capital
Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | ||
---|---|---|---|---|---|---|
Earnings before interest and tax (EBIT) | US$ in thousands | 53,315 | 72,747 | 85,018 | 80,186 | 70,125 |
Long-term debt | US$ in thousands | 282,289 | 311,541 | 272,925 | 382,710 | 368,257 |
Total stockholders’ equity | US$ in thousands | 256,641 | 282,509 | 262,442 | 238,529 | 188,204 |
Return on total capital | 9.89% | 12.25% | 15.88% | 12.91% | 12.60% |
June 30, 2024 calculation
Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $53,315K ÷ ($282,289K + $256,641K)
= 9.89%
Phibro Animal Health Corporation's return on total capital has shown a decreasing trend over the past five years. The return on total capital was 9.89% as of June 30, 2024, down from 12.25% in 2023, 15.88% in 2022, 12.91% in 2021, and 12.60% in 2020. This decline in the return on total capital indicates that the company's ability to generate profits from its total invested capital has weakened over time. It is important for the company to closely examine the factors contributing to this trend and take necessary steps to improve its returns on capital in order to enhance efficiency and profitability.
Peer comparison
Jun 30, 2024